In perpetuating and exacerbating restricted access to essential medicines, current trade-related intellectual property rules on medicines may violate core human rights to health and medicines. In this light, there should be serious questions about their necessity, and their justification should be critically assessed from the perspective of human rights standards. These standards require that international trade rules on medicines be justified to the fullest extent possible, and permitted only to the extent to which they can be justified.
In this article I explore the impact of trade rules on medicines access, and the growing force of the human right to health. I argue that the limited justification for strong patents in poor countries suggests the need for significant reform of trade-related intellectual property rights. I argue further that human rights standards may offer both normative and practical tools for achieving this reform and challenging trade rules on medicines at various levels.
To read or purchase the full text of this article, click here.
More in this issue
Fall 2007 (21.3) • Review
Ethics in Action: The Ethical Challenges of International Human Rights Nongovernmental Organizations edited by Daniel A. Bell and Jean-Marc Coicaud
Between 2002-2005, the UN University and the City University of Hong Kong organized a series of "dialogues" about the ethical challenges facing international nongovernmental organizations (...
Fall 2007 (21.3) • Essay
The Politics of PEPFAR: The President's Emergency Plan for AIDS Relief [Full Text]
In his January 2003 State of the Union Address, President Bush called for the U.S to commit $15 billion over five years to address the international ...
Fall 2007 (21.3) • Feature
Poverty and Global Justice
Poverty eradication has been identified as the largest challenge facing international society in its quest for a peaceful, prosperous, and just world. Kokaz responds to ...